Literature DB >> 9010394

Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study.

T A Ala1, K H Yang, J H Sung, W H Frey.   

Abstract

OBJECTIVES: To compare, in a retrospective clinicopathological study, the presentation features of patients with dementia and cortical Lewy bodies (Lewy body dementia) with those of patients with Alzheimer's disease.
METHODS: From a population of 426 cases from the dementia brain bank, 39 cases of Lewy body dementia and 61 cases of Alzheimer's disease with presentation details were identified.
RESULTS: The Lewy body dementia group had significantly more frequent hallucinations (23% v 3%, P = 0.006) and signs of parkinsonism (41% v 5%, P < 0.0001) than the Alzheimer's disease group. The Lewy body dementia group also had a greater proportion of men (62% v 34%, P = 0.013).
CONCLUSION: Hallucinations and signs of parkinsonism help distinguish Lewy body dementia from Alzheimer's disease at presentation. These indicators may not be very sensitive, because they were reported for less than half of the patients with Lewy body dementia.

Entities:  

Mesh:

Year:  1997        PMID: 9010394      PMCID: PMC486689          DOI: 10.1136/jnnp.62.1.16

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Lewy body variant.

Authors:  D W Dickson
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

Review 2.  Diffuse Lewy body disease in Japan.

Authors:  K Kosaka
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

3.  Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly.

Authors:  S Kuzuhara; M Yoshimura
Journal:  Adv Neurol       Date:  1993

4.  Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

Authors:  R H Perry; D Irving; G Blessed; A Fairbairn; E K Perry
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

5.  The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Authors:  L Hansen; D Salmon; D Galasko; E Masliah; R Katzman; R DeTeresa; L Thal; M M Pay; R Hofstetter; M Klauber
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Diffuse Lewy body disease: clinical features in 15 cases.

Authors:  E J Byrne; G Lennox; J Lowe; R B Godwin-Austen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 8.  Lewy body disease.

Authors:  L A Hansen; D Galasko
Journal:  Curr Opin Neurol Neurosurg       Date:  1992-12

9.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Neuropathological diagnoses in elderly patients in Oslo: Alzheimer's disease, Lewy body disease, vascular lesions.

Authors:  P G Ince; F K McArthur; E Bjertness; A Torvik; J M Candy; J A Edwardson
Journal:  Dementia       Date:  1995 May-Jun
View more
  13 in total

1.  Visual hallucinations: differential diagnosis and treatment.

Authors:  Ryan C Teeple; Jason P Caplan; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 2.  Dementia with Lewy bodies: clinical features and treatment.

Authors:  S Campbell; S Stephens; C Ballard
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 2.

Authors:  T C Booth; M Nathan; A D Waldman; A-M Quigley; A H Schapira; J Buscombe
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

Review 4.  Neuropsychiatric aspects of dementia with Lewy bodies.

Authors:  N Hirono; J L Cummings
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 5.  Posterior cortical atrophy: a brief review.

Authors:  Howard S Kirshner; Patrick J M Lavin
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

6.  MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.

Authors:  Bing Zhang; Tanis J Ferman; Bradley F Boeve; Glenn E Smith; Mandie Maroney-Smith; Anthony J Spychalla; David S Knopman; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2014-07-15       Impact factor: 2.486

Review 7.  Benefit-risk considerations in the treatment of dementia with Lewy bodies.

Authors:  Margaret M Swanberg; Jeffrey L Cummings
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 8.  Dementia with Lewy bodies.

Authors:  Tanis J Ferman; Bradley F Boeve
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

9.  Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.

Authors:  T J Ferman; Z Arvanitakis; H Fujishiro; R Duara; F Parfitt; M Purdy; C Waters; W Barker; N R Graff-Radford; D W Dickson
Journal:  Parkinsonism Relat Disord       Date:  2012-11-20       Impact factor: 4.891

Review 10.  Visual hallucinations related to angiotensin-converting enzyme inhibitor use: case reports and review.

Authors:  John Doane; Barry Stults
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-01-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.